Peroxisome Proliferator Activated Receptor Alpha (PPAR) Agonists: A Potential Tool for a Healthy Aging Brain

QR Code

Peroxisome Proliferator Activated Receptor Alpha (PPAR) Agonists: A Potential Tool for a Healthy Aging Brain

None

Saved in:

Bibliographic Details
Main Author:	Tremblay-Mercier, Jennifer
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/32123
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia
by: Barroso, Emma, et al.
Published: (2012)

CLINICAL EFFICACY AND SAFETY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL CONTROLLED STUDY
by: V. S. Shirinsky, et al.
Published: (2014-07-01)

Role of Nuclear Receptors Peroxisome Proliferator-Activated Receptors (PPARs) and Liver X Receptors (LXRs) in the Human Placental Pathophysiology
by: Marceau, Geoffroy, et al.
Published: (2012)

Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists for Patients With Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid (UDCA): A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Maadeha H. Zaidi, et al.
Published: (2025-06-01)

Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma
by: Rui Liu, et al.
Published: (2017-04-01)

Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects
by: Zijun Wu, et al.
Published: (2026-04-01)

Alpha‐Lipoic Acid Alleviates Isoflurane‐Induced Cognitive Dysfunction in Juvenile Mice by Activating Peroxisome Proliferator Activated Receptor Gamma Coactivator ‐1 Alpha
by: Xingkai Zhao, et al.
Published: (2025-07-01)

Physiological regulation of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha in mitochondrial metabolism during physical exercises: a systematic review
by: N. Ayubi, et al.
Published: (2025-06-01)

Role of peroxisome proliferator-activated receptor α and ϒ-2 in primary and secondary prophylaxis of atherosclerosis
by: Z. I. Ionova, et al.
Published: (2016-06-01)

The Role of 13-Hydroxyoctadecadienoic Acid, 15-Lipoxygenase, and Peroxisome Proliferator-Activated Receptor Alpha Gene Polymorphism (rs1800206) in Acute Coronary Syndrome: Pathophysiological Insights and Biomarker Relevance
by: Abdullah Abdulsattar Raeef, et al.
Published: (2025-07-01)

ANALGESIC POTENTIAL OF PURINE RECEPTOR AGONISTS AND B VITAMINS IN THE TREATMENT OF DIABETIC POLYNEUROPATHY
by: O. A. Demidova, et al.
Published: (2018-03-01)

Exploring the role of curcumin, nanocurcumin, and a PPAR agonist in preventing paraquat-induced systemic inflammation and oxidative stress in rats
by: Mahboobeh Ghasemzadeh Rahbardar, et al.
Published: (2025-07-01)

Place of imidazoline receptor agonists in the treatment of hypertension
by: D. V. Nebieridze, et al.
Published: (2022-01-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Peroxisomal Biogenesis: Genetic Disorders Reveal the Mechanisms
by: Santos, Manuel J., et al.
Published: (2011)

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: V. S. Shirinsky, et al.
Published: (2017-05-01)

Unravelling the Adiponectin Hallmark and Exploring the Therapeutic Potential of Its Receptor Agonists in Cancer Metabolic Reprogramming
by: Sanober Kafeel, et al.
Published: (2025-06-01)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

The peroxisomal matrix shuttling receptor Pex5 plays a role in FB1 production and virulence in Fusarium verticillioides
by: Wen-ying YU, et al.
Published: (2022-10-01)

CD36-Retinoic Acid- FABP5- PPARδ Signaling Axis Primes Neonatal Cardiomyocytes to Spontaneously Proliferate
by: Abou Bakr Salama, et al.
Published: (2025-06-01)

Peroxisomal ether-glycerophospholipid synthesis is dysregulated after TBI
by: Amir A. Mehrabani-Tabari, et al.
Published: (2025-06-01)

Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
by: Zhixuan Xie, et al.
Published: (2025-07-01)

Imidazoline receptor agonists: more than blood pressure reduction?
by: D. V. Nebieridze, et al.
Published: (2006-04-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

Prediction of compounds from breadfruit plants <i>(Artocarpus altilis)</i> as alpha estrogen receptor agonists for novel breast cancer anticancer therapy: an in silico approach
by: N. Su’aida, et al.
Published: (2025-05-01)

Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Mona Hassan, et al.
Published: (2025-06-01)

Research progress on the metabolic functions and protein compositions of plant peroxisomes
by: ZHANG Yuchan, et al.
Published: (2024-10-01)

The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review
by: Kamil Turlej, et al.
Published: (2025-07-01)

Utilizing computational approaches for the prediction of alpha-PPAR inhibitors from baobab (Adansonia digitata) against non-alcoholic fatty liver disease
by: Asia Awad AbdelGader, et al.
Published: (2024-12-01)

Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy
by: A. N. Britov, et al.
Published: (2006-02-01)

Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists
by: Chuu, Chih-Pin, et al.
Published: (2011)

Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)
by: Fujii, Hideaki, et al.
Published: (2012)

Drug Design Approaches to Manipulate the Agonist-Antagonist Equilibrium in Steroid Receptors
by: Lusher, Scott J., et al.
Published: (2012)

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01)

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations
by: Sarah L Anderson
Published: (2025-07-01)

Bitter taste receptor agonists induce vasorelaxation in porcine coronary arteries
by: Ching-Chung Tsai, et al.
Published: (2025-07-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)